Overlapping effector interfaces define the multiple functions of the HIV-1 Nef polyproline helix

Retrovirology

Volumn 9, Issue , 2012, Pages

  Kuo, Lillian S ^b   Baugh, Laura L ^b   Denial, Sarah J ^a   Watkins, Richard L ^a   Liu, Mingjie ^a   Garcia, J V ^a   Foster, John L ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

CD4; HIV 1; MHC class I; Nef; P21 activated protein kinase; Protein protein interaction interface; SH3 domain

Indexed keywords

ARGININE; GLUTAMINE; GLYCINE; GREEN FLUORESCENT PROTEIN; HEMATOPOIETIC CELL KINASE; LEUCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NEF PROTEIN; P21 ACTIVATED KINASE 2; PHENYLALANINE; PROLINE; PROTEIN SH3; TRANSCRIPTION FACTOR AP 1; VALINE;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CYTOPLASM; DOWN REGULATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MUTATIONAL ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; VIRION; VIRUS INFECTIVITY;

ADAPTATION, BIOLOGICAL; AMINO ACID MOTIFS; ARGININE; BLOTTING, WESTERN; GENES, MHC CLASS I; HEK293 CELLS; HELA CELLS; HIV INFECTIONS; HIV-1; HUMANS; MUTATION; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PEPTIDES; PROLINE; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; SRC HOMOLOGY DOMAINS; TRANSFECTION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84861627468     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-9-47     Document Type: Article

References (72)

1. Fackler OT, Moris A, Tibroni N, Giese SI, Glass B, Schwartz O, Krausslich HG. Functional characterization of HIV-1 Nef mutants in the context of viral infection. Virology 2006, 351:322-339. 10.1016/j.virol.2006.03.044, 16684552.
2. Foster JL, Garcia JV. HIV-1 Nef: at the crossroads. Retrovirology 2008, 5:84. 10.1186/1742-4690-5-84, 2563024, 18808677.
3. Foster JL, Garcia JV. Role of Nef in HIV-1 replication and pathogenesis. Adv Pharmacol 2007, 55:389-409.
4. Olivieri KC, Mukerji J, Gabuzda D. Nef-mediated enhancement of cellular activation and human immunodeficiency virus type 1 replication in primary T cells is dependent on association with p21-activated kinase 2. Retrovirology 2011, 8:64. 10.1186/1742-4690-8-64, 3169461, 21819585.
5. Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998, 391:397-401. 10.1038/34929, 9450757.
6. Tomiyama H, Akari H, Adachi A, Takiguchi M. Different effects of Nef-mediated HLA class I down-regulation on human immunodeficiency virus type 1-specific CD8(+) T-cell cytolytic activity and cytokine production. J Virol 2002, 76:7535-7543. 10.1128/JVI.76.15.7535-7543.2002, 136399, 12097566.
7. Yang OO, Nguyen PT, Kalams SA, Dorfman T, Gottlinger HG, Stewart S, Chen IS, Threlkeld S, Walker BD. Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes. J Virol 2002, 76:1626-1631. 10.1128/JVI.76.4.1626-1631.2002, 135916, 11799157.
8. Cortes MJ, Wong-Staal F, Lama J. Cell surface CD4 interferes with the infectivity of HIV-1 particles released from T cells. J Biol Chem 2002, 277:1770-1779. 10.1074/jbc.M109807200, 11704677.
9. Lundquist CA, Tobiume M, Zhou J, Unutmaz D, Aiken C. Nef-mediated downregulation of CD4 enhances human immunodeficiency virus type 1 replication in primary T lymphocytes. J Virol 2002, 76:4625-4633. 10.1128/JVI.76.9.4625-4633.2002, 155097, 11932428.
10. Ross TM, Oran AE, Cullen BR. Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein. Curr Biol 1999, 9:613-621. 10.1016/S0960-9822(99)80283-8, 10375525.
11. Pizzato M, Helander A, Popova E, Calistri A, Zamborlini A, Palu G, Gottlinger HG. Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef. Proc Natl Acad Sci U S A 2007, 104:6812-6817. 10.1073/pnas.0607622104, 1871867, 17412836.
12. Baur AS. HIV-Nef and AIDS pathogenesis: are we barking up the wrong tree?. Trends Microbiol 2011, 19:435-440. 10.1016/j.tim.2011.06.002, 21795047.
13. Mitchell RS, Chaudhuri R, Lindwasser OW, Tanaka KA, Lau D, Murillo R, Bonifacino JS, Guatelli JC. Competition model for upregulation of the major histocompatibility complex class II-associated invariant chain by human immunodeficiency virus type 1 Nef. J Virol 2008, 82:7758-7767. 10.1128/JVI.02668-07, 2519569, 18524831.
14. Grzesiek S, Stahl SJ, Wingfield PT, Bax A. The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR. Biochemistry 1996, 35:10256-10261. 10.1021/bi9611164, 8756680.
15. Noviello CM, Benichou S, Guatelli JC. Cooperative binding of the class I major histocompatibility complex cytoplasmic domain and human immunodeficiency virus type 1 Nef to the endosomal AP-1 complex via its mu subunit. J Virol 2008, 82:1249-1258. 10.1128/JVI.00660-07, 2224416, 18057255.
16. Preusser A, Briese L, Baur AS, Willbold D. Direct in vitro binding of full-length human immunodeficiency virus type 1 Nef protein to CD4 cytoplasmic domain. J Virol 2001, 75:3960-3964. 10.1128/JVI.75.8.3960-3964.2001, 114886, 11264384.
17. Preusser A, Briese L, Willbold D. Presence of a helix in human CD4 cytoplasmic domain promotes binding to HIV-1 Nef protein. Biochem Biophys Res Commun 2002, 292:734-740. 10.1006/bbrc.2002.6700, 11922627.
18. Singh RK, Lau D, Noviello CM, Ghosh P, Guatelli JC. An MHC-I cytoplasmic domain/HIV-1 Nef fusion protein binds directly to the mu subunit of the AP-1 endosomal coat complex. PLoS One 2009, 4:e8364. 10.1371/journal.pone.0008364, 2791223, 20020046.
19. Wonderlich ER, Williams M, Collins KL. The tyrosine binding pocket in the adaptor protein 1 (AP-1) mu1 subunit is necessary for Nef to recruit AP-1 to the major histocompatibility complex class I cytoplasmic tail. J Biol Chem 2008, 283:3011-3022.
20. Manninen A, Hiipakka M, Vihinen M, Lu W, Mayer BJ, Saksela K. SH3-Domain binding function of HIV-1 Nef is required for association with a PAK-related kinase. Virology 1998, 250:273-282. 10.1006/viro.1998.9381, 9792838.
21. Dikeakos JD, Atkins KM, Thomas L, Emert-Sedlak L, Byeon IJ, Jung J, Ahn J, Wortman MD, Kukull B, Saito M, et al. Small molecule inhibition of HIV-1-induced MHC-I down-regulation identifies a temporally regulated switch in Nef action. Mol Biol Cell 2010, 21:3279-3292. 10.1091/mbc.E10-05-0470, 2947465, 20702582.
22. Youker RT, Shinde U, Day R, Thomas G. At the crossroads of homoeostasis and disease: roles of the PACS proteins in membrane traffic and apoptosis. Biochem J 2009, 421:1-15. 10.1042/BJ20081016, 19505291.
23. Arold S, Franken P, Strub MP, Hoh F, Benichou S, Benarous R, Dumas C. The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling. Structure 1997, 5:1361-1372. 10.1016/S0969-2126(97)00286-4, 9351809.
24. Lee CH, Saksela K, Mirza UA, Chait BT, Kuriyan J. Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell 1996, 85:931-942. 10.1016/S0092-8674(00)81276-3, 8681387.
25. Kay BK, Williamson MP, Sudol M. The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains. FASEB J 2000, 14:231-241.
26. Li SS. Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transduction. Biochem J 2005, 390:641-653. 1199657, 16134966.
27. Musacchio A. How SH3 domains recognize proline. Adv Protein Chem 2002, 61:211-268.
28. Zarrinpar A, Bhattacharyya RP, Lim WA. The structure and function of proline recognition domains. Sci STKE 2003, 2003:RE8.
29. Baugh LL, Garcia JV, Foster JL. Functional characterization of the human immunodeficiency virus type 1 Nef acidic domain. J Virol 2008, 82:9657-9667. 10.1128/JVI.00107-08, 2546962, 18653452.
30. Casartelli N, Giolo G, Neri F, Haller C, Potesta M, Rossi P, Fackler OT, Doria M. The Pro78 residue regulates the capacity of the human immunodeficiency virus type 1 Nef protein to inhibit recycling of major histocompatibility complex class I molecules in an SH3-independent manner. J Gen Virol 2006, 87:2291-2296. 10.1099/vir.0.81775-0, 16847125.
31. Kwak YT, Raney A, Kuo LS, Denial SJ, Temple BR, Garcia JV, Foster JL. Self-association of the Lentivirus protein, Nef. Retrovirology 2010, 7:77. 10.1186/1742-4690-7-77, 2955668, 20863404.
32. O'Neill E, Kuo LS, Krisko JF, Tomchick DR, Garcia JV, Foster JL. Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef. J Virol 2006, 80:1311-1320. 10.1128/JVI.80.3.1311-1320.2006, 1346962, 16415008.
33. Yamada T, Kaji N, Odawara T, Chiba J, Iwamoto A, Kitamura Y. Proline 78 is crucial for human immunodeficiency virus type 1 Nef to down-regulate class I human leukocyte antigen. J Virol 2003, 77:1589-1594. 10.1128/JVI.77.2.1589-1594.2003, 140770, 12502873.
34. Jia X, Singh R, Homann S, Yang H, Guatelli J, Xiong Y. Structural Basis of HIV-1 Nef mediated Down-regulation of MHC-1. 19th Conference on Retroviruses and Opportunistic Infections 2012, Paper #40LB.
35. Henikoff S, Henikoff JG. Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci U S A 1992, 89:10915-10919. 10.1073/pnas.89.22.10915, 50453, 1438297.
36. Arold S, O'Brien R, Franken P, Strub MP, Hoh F, Dumas C, Ladbury JE. RT loop flexibility enhances the specificity of Src family SH3 domains for HIV-1 Nef. Biochemistry 1998, 37:14683-14691. 10.1021/bi980989q, 9778343.
37. Lee CH, Leung B, Lemmon MA, Zheng J, Cowburn D, Kuriyan J, Saksela K. A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. Embo J 1995, 14:5006-5015. 394604, 7588629.
38. Collette Y, Arold S, Picard C, Janvier K, Benichou S, Benarous R, Olive D, Dumas C. HIV-2 and SIV nef proteins target different Src family SH3 domains than does HIV-1 Nef because of a triple amino acid substitution. J Biol Chem 2000, 275:4171-4176. 10.1074/jbc.275.6.4171, 10660579.
39. Arora VK, Molina RP, Foster JL, Blakemore JL, Chernoff J, Fredericksen BL, Garcia JV. Lentivirus Nef specifically activates Pak2. J Virol 2000, 74:11081-11087. 10.1128/JVI.74.23.11081-11087.2000, 113188, 11070003.
40. Wei BL, Arora VK, Raney A, Kuo LS, Xiao GH, O'Neill E, Testa JR, Foster JL, Garcia JV. Activation of p21-activated kinase 2 by human immunodeficiency virus type 1 Nef induces merlin phosphorylation. J Virol 2005, 79:14976-14980. 10.1128/JVI.79.23.14976-14980.2005, 1287594, 16282498.
41. Wiskerchen M, Cheng-Mayer C. HIV-1 Nef association with cellular serine kinase correlates with enhanced virion infectivity and efficient proviral DNA synthesis. Virology 1996, 224:292-301. 10.1006/viro.1996.0531, 8862424.
42. Karkkainen S, Hiipakka M, Wang JH, Kleino I, Vaha-Jaakkola M, Renkema GH, Liss M, Wagner R, Saksela K. Identification of preferred protein interactions by phage-display of the human Src homology-3 proteome. EMBO Rep 2006, 7:186-191. 10.1038/sj.embor.7400596, 1369250, 16374509.
43. Renkema GH, Manninen A, Saksela K. Human immunodeficiency virus type 1 Nef selectively associates with a catalytically active subpopulation of p21-activated kinase 2 (PAK2) independently of PAK2 binding to Nck or beta-PIX. J Virol 2001, 75:2154-2160. 10.1128/JVI.75.5.2154-2160.2001, 114799, 11160719.
44. Blagoveshchenskaya AD, Thomas L, Feliciangeli SF, Hung CH, Thomas G. HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway. Cell 2002, 111:853-866. 10.1016/S0092-8674(02)01162-5, 12526811.
45. Greenberg ME, Iafrate AJ, Skowronski J. The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes. Embo J 1998, 17:2777-2789. 10.1093/emboj/17.10.2777, 1170618, 9582271.
46. Wonderlich ER, Leonard JA, Kulpa DA, Leopold KE, Norman JM, Collins KL. ADP ribosylation factor 1 activity is required to recruit AP-1 to the major histocompatibility complex class I (MHC-I) cytoplasmic tail and disrupt MHC-I trafficking in HIV-1-infected primary T cells. J Virol 2011, 85:12216-12226. 10.1128/JVI.00056-11, 3209341, 21917951.
47. Craig HM, Pandori MW, Riggs NL, Richman DD, Guatelli JC. Analysis of the SH3-binding region of HIV-1 nef: partial functional defects introduced by mutations in the polyproline helix and the hydrophobic pocket. Virology 1999, 262:55-63. 10.1006/viro.1999.9897, 10489340.
48. Goldsmith MA, Warmerdam MT, Atchison RE, Miller MD, Greene WC. Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef. J Virol 1995, 69:4112-4121. 189146, 7769669.
49. Chutiwitoonchai N, Hiyoshi M, Mwimanzi P, Ueno T, Adachi A, Ode H, Sato H, Fackler OT, Okada S, Suzu S. The identification of a small molecule compound that reduces HIV-1 Nef-mediated viral infectivity enhancement. PLoS One 2011, 6:e27696. 10.1371/journal.pone.0027696, 3217016, 22110726.
50. Luo T, Livingston RA, Garcia JV. Infectivity enhancement by human immunodeficiency virus type 1 Nef is independent of its association with a cellular serine/threonine kinase. J Virol 1997, 71:9524-9530. 230259, 9371615.
51. Lo Conte L, Chothia C, Janin J. The atomic structure of protein-protein recognition sites. J Mol Biol 1999, 285:2177-2198. 10.1006/jmbi.1998.2439, 9925793.
52. Choi HJ, Smithgall TE. Conserved residues in the HIV-1 Nef hydrophobic pocket are essential for recruitment and activation of the Hck tyrosine kinase. J Mol Biol 2004, 343:1255-1268. 10.1016/j.jmb.2004.09.015, 15491611.
53. Liu LX, Heveker N, Fackler OT, Arold S, Le Gall S, Janvier K, Peterlin BM, Dumas C, Schwartz O, Benichou S, Benarous R. Mutation of a conserved residue (D123) required for oligomerization of human immunodeficiency virus type 1 Nef protein abolishes interaction with human thioesterase and results in impairment of Nef biological functions. J Virol 2000, 74:5310-5319. 10.1128/JVI.74.11.5310-5319.2000, 110886, 10799608.
54. Foster JL, Denial SJ, Temple BR, Garcia JV. Mechanisms of HIV-1 Nef function and intracellular signaling. J Neuroimmune Pharmacol 2011, 6:230-246. 10.1007/s11481-011-9262-y, 21336563.
55. Bogan AA, Thorn KS. Anatomy of hot spots in protein interfaces. J Mol Biol 1998, 280:1-9. 10.1006/jmbi.1998.1843, 9653027.
56. Cunningham BC, Wells JA. Comparison of a structural and a functional epitope. J Mol Biol 1993, 234:554-563. 10.1006/jmbi.1993.1611, 7504735.
57. Ali SA, Huang MB, Campbell PE, Roth WW, Campbell T, Khan M, Newman G, Villinger F, Powell MD, Bond VC. Genetic characterization of HIV type 1 Nef-induced vesicle secretion. AIDS Res Hum Retroviruses 2010, 26:173-192. 10.1089/aid.2009.0068, 2835390, 20156100.
58. Shelton MN, Huang MB, Ali SA, Powell MD, Bond VC. Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release. J Virol 2012, 86:406-419. 10.1128/JVI.05720-11, 3255900, 22013042.
59. Jung J, Byeon IJ, Ahn J, Gronenborn AM. Structure, dynamics, and Hck interaction of full-length HIV-1 Nef. Proteins 2011, 79:1609-1622. 10.1002/prot.22986, 3076547, 21365684.
60. Arold S, Hoh F, Domergue S, Birck C, Delsuc MA, Jullien M, Dumas C. Characterization and molecular basis of the oligomeric structure of HIV-1 nef protein. Protein Sci 2000, 9:1137-1148. 10.1110/ps.9.6.1137, 2144662, 10892807.
61. Poe JA, Smithgall TE. HIV-1 Nef dimerization is required for Nef-mediated receptor downregulation and viral replication. J Mol Biol 2009, 394:329-342. 10.1016/j.jmb.2009.09.047, 2783173, 19781555.
62. Petersen JL, Morris CR, Solheim JC. Virus evasion of MHC class I molecule presentation. J Immunol 2003, 171:4473-4478.
63. Swigut T, Iafrate AJ, Muench J, Kirchhoff F, Skowronski J. Simian and human immunodeficiency virus Nef proteins use different surfaces to downregulate class I major histocompatibility complex antigen expression. J Virol 2000, 74:5691-5701. 10.1128/JVI.74.12.5691-5701.2000, 112057, 10823877.
64. Akari H, Arold S, Fukumori T, Okazaki T, Strebel K, Adachi A. Nef-induced major histocompatibility complex class I down-regulation is functionally dissociated from its virion incorporation, enhancement of viral infectivity, and CD4 down-regulation. J Virol 2000, 74:2907-2912. 10.1128/JVI.74.6.2907-2912.2000, 111784, 10684310.
65. Iijima S, Lee YJ, Ode H, Arold S, Kimura N, Yokoyama M, Sato H, Tanaka Y, Strebel K, Akari H. A non-canonical mu-1A-binding motif in the N-terminus of HIV-1 Nef determines its activity to down-regulate MHC-I in T lymphocytes. J Virol 2012, 86:3944-3951. 10.1128/JVI.06257-11, 22301137.
66. Denton PW, Estes JD, Sun Z, Othieno FA, Wei BL, Wege AK, Powell DA, Payne D, Haase AT, Garcia JV. Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. PLoS Med 2008, 5:e16. 10.1371/journal.pmed.0050016, 2194746, 18198941.
67. Denton PW, Krisko JF, Powell DA, Mathias M, Kwak YT, Martinez-Torres F, Zou W, Payne DA, Estes JD, Garcia JV. Systemic administration of antiretrovirals prior to exposure prevents rectal and intravenous HIV-1 transmission in humanized BLT mice. PLoS One 2010, 5:e8829. 10.1371/journal.pone.0008829, 2809117, 20098623.
68. Melkus MW, Estes JD, Padgett-Thomas A, Gatlin J, Denton PW, Othieno FA, Wege AK, Haase AT, Garcia JV. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med 2006, 12:1316-1322. 10.1038/nm1431, 17057712.
69. Zou W, Denton PW, Watkins R, Krisko JF, Nochi T, Foster JL, Victor Garcia J. Nef functions in BLT mice to enhance HIV-1 replication and deplete CD4+CD8+ 2 thymocytes. Retrovirology 2012, 2012:2012. in press.
70. Meuwissen PJ, Stolp B, Iannucci V, Vermeire J, Naessens E, Saksela K, Geyer M, Vanham G, Arien KK, Fackler OT, Verhasselt B. Identification of a highly conserved valine-glycine-phenylalanine amino acid triplet required for HIV-1 Nef function. Retrovirology 2012, 9:34. 10.1186/1742-4690-9-34, 22537596.
71. Betzi S, Restouin A, Opi S, Arold ST, Parrot I, Guerlesquin F, Morelli X, Collette Y. Protein protein interaction inhibition (2P2I) combining high throughput and virtual screening: Application to the HIV-1 Nef protein. Proc Natl Acad Sci U S A 2007, 104:19256-19261. 10.1073/pnas.0707130104, 2148277, 18042718.
72. Foster JL, Molina RP, Luo T, Arora VK, Huang Y, Ho DD, Garcia JV. Genetic and functional diversity of human immunodeficiency virus type 1 subtype B Nef primary isolates. J Virol 2001, 75:1672-1680. 10.1128/JVI.75.4.1672-1680.2001, 114076, 11160665.